
HPV Vaccine Slashes Cervical Cancer Risk in Long-Term Swedish Study
A Swedish nationwide study following nearly a million girls and young women for up to 18 years shows the HPV vaccine substantially lowers cervical cancer risk, especially when given before age 17, with protection persisting for at least 18 years and supporting gender-neutral vaccination programs.













